Loss of heterozygosity (LOH) of the wild-type allele to accompany hereditary pathogenic variants in BRCA1 or BRCA2 is predicted to lead to loss of function (LOF) of these genes and increases genomic instability during breast cancer development [15]. This evidence concerns the gene BRCA2 and breast cancer.